医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Attributable liver cancer deaths and disability-adjusted life years in China and worldwide:profiles and changing trends

摘要Objective:Liver cancer is a major health concern globally and in China.This analysis investigated deaths and disability-adjusted life years(DALYs)with respect to etiologies and risk factors for liver cancer in China and worldwide.Methods:Global and China-specific data were collected on liver cancer deaths,DALYs,and age-standardized rates(ASRs)from the Global Burden of Disease Study 2019 database.Liver cancer etiologies were classified into five groups and risk factors were categorized into three levels.Each proportion of liver cancer burden was calculated in different geographic regions.The joinpoint regression model were used to assess the trends from 1990-2019.Results:Liver cancer accounted for 484,577 deaths worldwide in 2019 with an ASR of 5.9 per 100,000 population.China had an elevated liver cancer death ASR in 2019 and males had an ASR 1.7 times the global rate.The global ASR for DALYs peaked at 75-79 years of age but peaked earlier in China.Hepatitis B virus was the prominent etiology globally(39.5%)and in China(62.5%),followed by hepatitis C virus and alcohol consumption.In high sociodemographic index countries,non-alcoholic steatohepatitis has gained an increasing contribution as an etiologic factor.The liver cancer burden due to various etiologies has decreased globally in both genders.However,metabolic risk factors,particularly obesity,have had a growing contribution to the liver cancer burden,especially among males.Conclusions:Despite an overall decreasing trend in the liver cancer burden in China and worldwide,there has been a rising contribution from metabolic risk factors,highlighting the importance of implementing targeted prevention and control strategies that address regional and gender disparities.

更多
广告
作者 Mengdi Cao [1] Changfa Xia [1] Maomao Cao [1] Fan Yang [1] Xinxin Yan [1] Siyi He [1] Shaoli Zhang [1] Yi Teng [1] Qianru Li [1] Nuopei Tan [1] Jiachen Wang [1] Wanqing Chen [1] 学术成果认领
作者单位 Office of Cancer Screening,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China [1]
栏目名称
DOI 10.20892/j.issn.2095-3941.2024.0149
发布时间 2024-09-05(万方平台首次上网日期,不代表论文的发表时间)
提交
  • 浏览8
  • 下载3
癌症生物学与医学(英文版)

癌症生物学与医学(英文版)

2024年21卷8期

679-691页

SCIMEDLINEISTICCSCDCABP

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷